Effects of PB-94 (sevelamer hydrochloride), a phosphate binder, on the treatment of hyperphosphatemia in hemodialysis patients—A randomized, open label, dose titration study of PB-94 versus Caltan tablet 500 (calcium carbonate)

Authors
Category Primary study
JournalJournal of American Society of Nephology
Year 2001
This article has no abstract
Epistemonikos ID: 237e44c112b244dc44b3896ac10d9afe6de079ff
First added on: Sep 01, 2016